Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 1
1967 1
1969 3
1971 1
1972 3
1973 3
1974 4
1975 2
1976 4
1977 4
1978 8
1979 2
1980 5
1981 7
1982 13
1983 12
1984 3
1985 8
1986 4
1987 4
1988 4
1989 7
1990 4
1991 7
1992 4
1993 2
1994 2
1995 1
1996 7
1997 8
1998 4
1999 2
2000 8
2001 7
2002 6
2003 1
2004 9
2005 3
2006 10
2007 11
2008 5
2009 4
2010 4
2011 16
2012 11
2013 12
2014 13
2015 8
2016 7
2017 7
2018 7
2019 11
2020 11
2021 20
2022 10
Text availability
Article attribute
Article type
Publication date

Search Results

322 results
Results by year
Filters applied: . Clear all
Page 1
Systemic diseases and the cornea.
Shah R, Amador C, Tormanen K, Ghiam S, Saghizadeh M, Arumugaswami V, Kumar A, Kramerov AA, Ljubimov AV. Shah R, et al. Exp Eye Res. 2021 Mar;204:108455. doi: 10.1016/j.exer.2021.108455. Epub 2021 Jan 21. Exp Eye Res. 2021. PMID: 33485845 Free PMC article. Review.
These include endocrine disorders (diabetes, Graves' disease, Addison's disease, hyperparathyroidism), infections with viruses (SARS-CoV-2, herpes simplex, varicella zoster, HTLV-1, Epstein-Barr virus) and bacteria (tuberculosis, syphilis and Pseudomonas aeruginosa) …
These include endocrine disorders (diabetes, Graves' disease, Addison's disease, hyperparathyroidism), infections with viruses (SARS-CoV-2, …
Positive association of herpes simplex virus-IgG with multiple sclerosis: A systematic review and meta-analysis.
Xu L, Zhang LJ, Yang L, Yang CS, Yi M, Zhang SN, Wang N, Huang CN, Liu MQ. Xu L, et al. Mult Scler Relat Disord. 2021 Jan;47:102633. doi: 10.1016/j.msard.2020.102633. Epub 2020 Nov 19. Mult Scler Relat Disord. 2021. PMID: 33254090
BACKGROUND: Multiple sclerosis (MS) is the most common chronic inflammatory demyelinating disease of the central nervous system (CNS), and whether herpes simplex virus (HSV) infection is associated with the development of MS remains controversial. ...M …
BACKGROUND: Multiple sclerosis (MS) is the most common chronic inflammatory demyelinating disease of the central nervous syste …
Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis.
Cohen JA, Barkhof F, Comi G, Hartung HP, Khatri BO, Montalban X, Pelletier J, Capra R, Gallo P, Izquierdo G, Tiel-Wilck K, de Vera A, Jin J, Stites T, Wu S, Aradhye S, Kappos L; TRANSFORMS Study Group. Cohen JA, et al. N Engl J Med. 2010 Feb 4;362(5):402-15. doi: 10.1056/NEJMoa0907839. Epub 2010 Jan 20. N Engl J Med. 2010. PMID: 20089954 Free article. Clinical Trial.
BACKGROUND: Fingolimod (FTY720), a sphingosine-1-phosphate-receptor modulator that prevents lymphocyte egress from lymph nodes, showed clinical efficacy and improvement on imaging in a phase 2 study involving patients with multiple sclerosis. METHODS: In this 12-mon …
BACKGROUND: Fingolimod (FTY720), a sphingosine-1-phosphate-receptor modulator that prevents lymphocyte egress from lymph nodes, showed clini …
Recent developments on PET radiotracers for TSPO and their applications in neuroimaging.
Zhang L, Hu K, Shao T, Hou L, Zhang S, Ye W, Josephson L, Meyer JH, Zhang MR, Vasdev N, Wang J, Xu H, Wang L, Liang SH. Zhang L, et al. Acta Pharm Sin B. 2021 Feb;11(2):373-393. doi: 10.1016/j.apsb.2020.08.006. Epub 2020 Aug 25. Acta Pharm Sin B. 2021. PMID: 33643818 Free PMC article. Review.
As the primary index of neuroinflammation, TSPO is implicated in the pathogenesis and progression of numerous neuropsychiatric disorders and neurodegenerative diseases, including Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), Parkinson's disease (PD), mu …
As the primary index of neuroinflammation, TSPO is implicated in the pathogenesis and progression of numerous neuropsychiatric disorders and …
What Can Mimic Multiple Sclerosis?
Jewells VL, Latchaw RE. Jewells VL, et al. Semin Ultrasound CT MR. 2020 Jun;41(3):284-295. doi: 10.1053/j.sult.2020.02.003. Epub 2020 Feb 29. Semin Ultrasound CT MR. 2020. PMID: 32448485 Review.
This article discusses mimics of multiple sclerosis (MS). Excluded in this discussion are neuromyelitis optica and vasculitis, discussed in other articles in this journal. Covered entities include posterior reversible encephalopathy syndrome, reversible vasoconstric …
This article discusses mimics of multiple sclerosis (MS). Excluded in this discussion are neuromyelitis optica and vasculitis, …
A comprehensive review of varicella-zoster virus, herpes simplex virus and cryptococcal infections associated with sphingosine-1-phosphate receptor modulators in multiple sclerosis patients.
Sharma K, Chaudhary D, Beard K, Srivastava S, Khalid SH, Sriwastava S. Sharma K, et al. Mult Scler Relat Disord. 2022 Mar;59:103675. doi: 10.1016/j.msard.2022.103675. Epub 2022 Feb 8. Mult Scler Relat Disord. 2022. PMID: 35168095 Review.
Sphingosine-1-phosphate (S1P) receptor modulators are a new class of oral disease-modifying therapies used for Multiple Sclerosis (MS). These are immunomodulatory drugs and can thus increase the risk of certain infections in these patients. This paper summarizes the …
Sphingosine-1-phosphate (S1P) receptor modulators are a new class of oral disease-modifying therapies used for Multiple Sclerosis …
Skin Reactions in Patients With Multiple Sclerosis Receiving Cladribine Treatment.
Rolfes L, Pfeuffer S, Hackert J, Pawlitzki M, Ruck T, Sondermann W, Korsen M, Wiendl H, Meuth SG, Kleinschnitz C, Pul R. Rolfes L, et al. Neurol Neuroimmunol Neuroinflamm. 2021 Apr 9;8(3):e990. doi: 10.1212/NXI.0000000000000990. Print 2021 May. Neurol Neuroimmunol Neuroinflamm. 2021. PMID: 33837059 Free PMC article.
OBJECTIVE: To report 77 patients with multiple sclerosis (MS) who developed skin-related adverse events (AEs) following treatment with cladribine. ...In 15 patients, herpes zoster infection was severe (CTCAE grade 3) and required hospitalization. ...
OBJECTIVE: To report 77 patients with multiple sclerosis (MS) who developed skin-related adverse events (AEs) following treatm …
Multiple sclerosis treatment with fingolimod: profile of non-cardiologic adverse events.
Fragoso YD. Fragoso YD. Acta Neurol Belg. 2017 Dec;117(4):821-827. doi: 10.1007/s13760-017-0794-7. Epub 2017 May 20. Acta Neurol Belg. 2017. PMID: 28528469 Review.
Fingolimod was the first oral medication approved for management of multiple sclerosis and is currently used by tens of thousands patients worldwide. ...However, the drug has other potential adverse events that, although relatively rare, require awareness from the n …
Fingolimod was the first oral medication approved for management of multiple sclerosis and is currently used by tens of thousa …
Subacute herpes simplex virus type 1 encephalitis as an initial presentation of chronic lymphocytic leukemia and multiple sclerosis: a case report.
Singhal RL, Corman LC. Singhal RL, et al. J Med Case Rep. 2011 Feb 11;5:59. doi: 10.1186/1752-1947-5-59. J Med Case Rep. 2011. PMID: 21314934 Free PMC article.
We report what we believe to be the first published case of a subacute course of herpes simplex virus type 1 encephalitis in a patient with asymptomatic chronic lymphocytic leukemia who subsequently developed multiple sclerosis. ...The development of …
We report what we believe to be the first published case of a subacute course of herpes simplex virus type 1 encephalitis in a …
Trials of antivirals in the treatment of multiple sclerosis.
Lycke J. Lycke J. Acta Neurol Scand. 2017 Nov;136 Suppl 201:45-48. doi: 10.1111/ane.12839. Acta Neurol Scand. 2017. PMID: 29068492 Review.
There is increasing evidence that human herpes viruses and human endogenous retroviruses (HERV) are involved in the aetiology and pathogenesis of multiple sclerosis (MS). ...
There is increasing evidence that human herpes viruses and human endogenous retroviruses (HERV) are involved in the aetiology and pat …
322 results